Amgen earnings top analyst forecasts
Amgen Inc. on Tuesday reported first-quarter net income of $1.62 billion.
On a per-share basis, the Thousand Oaks-based company said it had net income of $2.11. Earnings, adjusted for costs related to mergers and acquisitions, were $2.48 per share.
The results exceeded Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of $2.07 per share.
The world’s largest biotech drugmaker posted revenue of $5.03 billion in the period, also beating Street forecasts. Snalysts surveyed by Zacks expected $4.92 billion.
Amgen expects full-year earnings in the range of $9.35 to $9.65 per share, with revenue in the range of $20.9 billion to $21.3 billion.
Amgen shares have climbed almost 6 percent since the beginning of the year, while the Standard & Poor’s 500 index has climbed nearly 2 percent. In the final minutes of trading on Tuesday, shares hit $168.46, an increase of 44 percent in the last 12 months.
Your guide to our new economic reality.
Get our free business newsletter for insights and tips for getting by.
You may occasionally receive promotional content from the Los Angeles Times.
More From the Los Angeles Times
-
In March, slightly more than half of homes sold for over the asking price across Los Angeles. In some spots, the share was even bigger.
-
The president of Toshiba Corp. has stepped down after the company said it was studying an acquisition proposal from a fund where he previously worked.
-
Facebook’s quasi-independent Oversight Board says it will start letting users file appeals over posts, photos and videos that they think the company shouldn’t have allowed to stay on its platforms.
-
The head of the IRS calculated that tax evasion in the U.S. may be much more than previous estimates from the federal government.
